Clover Biopharmaceuticals, Ltd. (HKG:2197)

Hong Kong · Delayed Price · Currency is HKD

1.550

+0.100 (6.90%)

Jul 10, 2026, 10:50 AM HKT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Biotechnology	3.51M	38.42M	39.26M	-	-
Biotechnology Growth	-90.88%	-2.13%	-	-	-
Total	3.51M	38.42M	39.26M	-	-
Total Growth	-90.88%	-2.13%	-	-	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Mainland China	3.51M	35.18M	39.26M	-	-
Mainland China Growth	-90.04%	-10.39%	-	-	-
Korea	-	3.24M	-	-	-
Total	3.51M	38.42M	39.26M	-	-
Total Growth	-90.88%	-2.13%	-	-	-